News

A recent study presents a method for detecting Alzheimer's disease before neuronal damage becomes extensive. The study used small plasma particles called exosomes, obtained through liquid biopsy, because they carry molecular information from their cells of origin. Despite the difficulty involved, preliminary studies are very promising in terms of the ability to capture brain-derived exosomes. This could make it feasible to detect the disease at very early stages and move towards a tool to support screening and monitoring, which is the objective of the research.

IBB-UAB researcher Aura Muntasell has been selected one of the eight finalists for the fifteenth edition of the Vanguardia de la Ciència Award, a recognition that highlights the most outstanding contributions of research led by institutions in Spain. Her candidacy stands out for the development of an innovative immunotherapy strategy against cancer, with the potential to improve the effectiveness of current treatments. Voting to choose the winning research is open to the public until 28 June.

The visit takes place within the framework of the ECIU Seed project “BEAT”, in which the researcher Òscar Quijada participates as a partner

Ranking from “Research.com” 2026

How IBB is Connecting with Catalonia’s Microvillages

A research team led by UAB researcher David Reverter has discovered the molecular mechanism that describes in detail the process regulating cell division in bacteria, based on the binding of the MraZ protein to the dcw gene cluster. The research has been published in Nature Communications.

70 participants, 3 expert talks, and plenty of pizza: a vibrant look at the advances in biophysics that are redefining life at the molecular level.

The Spanish Society of Evolutionary Biology (SESBE) has awarded the Pere Alberch Prize for the best doctoral thesis in evolutionary biology to Laia Marín Gual, researcher at the Institute of Biotechnology and Biomedicine (IBB-UAB) and the Department of Cell Biology, Physiology and Immunology of the UAB.

Microvillages and Science Project: connecting communities in situ

A multidisciplinary team co-led by the UAB has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body through the P116 protein. The discovery, published in Nature Communications, opens the door to using a modified version of this microorganism as a biotechnological platform to study and treat liver and atherosclerotic diseases.